Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
5/29/2023
A Share-Listed Chinese MedPharm Cos Report Performance in 2022 with Ov...
5/29/2023
Review of Leading Listed Chinese Pharma Cos by R&D Spending in 2022
5/29/2023
SAMR Fines Two Chinese Drug Ingredient Suppliers for Monopolistic Beha...
5/26/2023
Moderna Looks to Build China Business with a Newly Established $100M L...
5/26/2023
Recent Executive Moves
5/26/2023
China's Middle Class – Growth, Policy, and Consumption (China Briefin...
5/24/2023
NMPA Solicits Comments on New Document on Strengthening Regulation of ...
5/24/2023
Yimi Research: 2023 Survey on Effective Communication Channels with Ch...
5/22/2023
PhIIC: Chinese Retail Pharmacy Sales Continued to Decline in Q1/2023
5/22/2023
Pharnexcloud: Chinese Hospital Drug Market Down Slightly in 2022 Under...
5/22/2023
SMEI: Chinese Terminal Drug Market Growth Slowed to 1.1% in 2022 (Upda...
5/22/2023
Doctor-influencers Ae Going Viral in China, Provoking Authorities (ROW...
5/19/2023
CStone Breaks Up With Drugs Partner As U.S. Rollout Stalls (Bamboo Wor...
5/19/2023
April Fundraising Rebounds with $315M Capital Injection to Hasten Biop...
5/19/2023
An AstraZeneca Executive Said the Quiet Part about China Out Loud (Qua...
5/19/2023
EQRx Terminates Licensing Agreement with CStone for Sugemalimab and No...
5/19/2023
uBriGene Acquires Mustang Bio's Facility in Worcester MA
5/19/2023
Recent Executive Moves
5/18/2023
Chinese A Shared-listed Pharma Companies Report Mixed Q1/2023 Performa...
5/17/2023
WuXi Bio Enters Manufacturing Partnership with InflaRx to Advance Gohi...
5/17/2023
BeiGene, Max Foundation Team Up to Provide Free Brukinsa to CLL Patien...
5/17/2023
Elevar, Hengrui Files Another China-made PD-1 for Liver Cancer in the ...
5/16/2023
NMPA and BfArM Sign Joint Declaration of Intent
5/16/2023
NHSA Issues Announcement on the Framework System for Intelligent Revie...
5/16/2023
China's Top 10 Homegrown Novel Drugs in 2022, Vaccines and Cancer Drug...
5/15/2023
China's $220 Billion Biotech Initiative Is Struggling to Take Off (Blo...
5/15/2023
Rona Thera and Keymed Enter Collaboration to Discover and Develop Firs...
5/15/2023
China Beefs Up Mental Health Efforts with a New Guideline
5/12/2023
AstraZeneca and LaNova Medicines Enter Global License Deal for GPRC5D...
5/12/2023
Recent Executive Moves
Page:
25
/
333
Total number of articles:
9989
:
[First]
[<<]
[23]
[24]
[25]
[26]
[27]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit